🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pathological Complete Remission

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer NCT07593976Phase 21 site📍 Rouen Centre Henri Becquerel · Tests: [68Ga]Ga-NOTA-anti-HER2-sdAb Positron Emission Tomography Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma NCT06755567n/a1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: MRI-based radiomics-clinical model Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients NCT05350722NA7 sites📍 Sydney📍 Almere Stad📍 Amstelveen Amsterdam UMC, location VUmc · Tests: Single dose ablative radiotherapy Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer NCT07327970n/a1 site📍 Incheon Young-Joon Kang · Tests: multi-modal foundation AI test 40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma NCT07328854Phase 315 sites📍 Hefei📍 Fuzhou📍 Guangzhou Ming-Yuan Chen · Tests: Cisplatin-based induction chemotherapy, Full course of PD-1 monoclonal antibody, Reduced-dose radiotherapy to CTV2, Con… Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients NCT04314219Phase 31 site📍 Riyadh King Faisal Specialist Hospital & Research Center · Tests: Cyclophosphamide 50mg, Methotrexate Watch and Wait as Treatment for Patients With Rectal Cancer NCT03125343NA2 sites📍 Gothenburg📍 Stockholm Sahlgrenska University Hospital · Tests: endoscopy, Surgery, MRI Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer NCT06220214EARLY Phase 11 site📍 Stony Brook Alison Stopeck · Tests: CEDM, CEDBT, Omnipaque 350mgI/mL Solution for Injection A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) NCT06312137Phase 3270 sites📍 Little Rock📍 Springdale📍 Beverly Hills Merck Sharp & Dohme LLC · Tests: Sacituzumab tirumotecan, Pembrolizumab, Cisplatin, Pemetrexed, Gemcitabine A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer NCT05563766Phase 27 sites📍 Palo Alto📍 Ann Arbor📍 Durham VA Office of Research and Development · Tests: Itraconazole Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait NCT05000697NA24 sites📍 Buenos Aires📍 Buenos Aires📍 Buenos Aires Hospital Alemão Oswaldo Cruz · Tests: Oxaliplatin, 5FU Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer NCT04643041NA1 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: watch and wait Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB) NCT04293796NA1 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology · Tests: Vacuum-assisted biopsy Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy NCT05866458n/a27 sites📍 Cudgen📍 Liverpool📍 North Sydney Ontario Clinical Oncology Group (OCOG) Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC NCT06601309Phase 21 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Serplulimab, Paclitaxel+Cisplatin (Neoadjuvant Chemotherapy), Paclitaxel+Cisplatin(Concurrent Chemoradiotherapy), Radio… Predicting Gastric Cancer Response to Chemo With Multimodal AI Model NCT06451393n/a1 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Neoadjuvant chemotherapy with radical tumor resection surgery DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy NCT05416164NA1 site📍 Amsterdam The Netherlands Cancer Institute · Tests: Omission of radiotherapy The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC NCT06182657n/a1 site📍 Nanchang Jiangxi Provincial Cancer Hospital The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR NCT05854823NA1 site📍 Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University · Tests: dose-reduced radiotherapy ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer NCT07841236Phase 21 site📍 Shanghai Fudan University · Tests: PD-1 inhibitor, CTLA-4 inhibitor, ctDNA/MRD testing, Curative Surgery Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors NCT07586826Phase 21 site📍 Beijing Peking University People's Hospital · Tests: Romiplostim N01, All-trans retinoic acid NearWave Optical Molecular Monitoring NCT06744465NA1 site📍 Indianapolis Indiana University · Tests: NearWave monitoring Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST) NCT05505357NA1 site📍 Seoul Seoul National University Hospital · Tests: Breast surgery omission Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer NCT07646301Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Iparomlimab and Tuvonralimab (QL1706), Paclitaxel, Cisplatin, Carboplatin Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer NCT07635342Phase 21 site📍 Shijiazhuang Hebei Medical University Fourth Hospital · Tests: Pyrotinib Maleate, Trastuzumab (H, 8mg/kg, pegylated liposomal doxorubicin hydrochloride, Cyclophosphamide, Paclitaxel … THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy NCT04815694NA1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial NCT07407920Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Hormone Therapy, Pembrolizumab, Pertuzumab, Trastuzumab Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS) NCT07855926n/a1 site📍 Munich LMU Klinikum · Tests: Perioperative Systemic Therapy Registry T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR NCT07353840n/a1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Autologous Hematopoietic Stem Cell Transplantation, Observation Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer NCT07353723Phase 21 site📍 Shanxi Tang-Du Hospital · Tests: Nimotuzumab, Toripalimab, Nab-paclitaxel, carboplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy